XML 43 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenues Revenues (Tables)
3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The Company’s revenues disaggregated by geography, based on the destination to which the Company ships its products, for the three months ended March 31, 2024 and 2023 was as follows (in thousands):
 Three Months Ended March 31,
 20242023
United States$209,644 $171,879 
International69,011 69,519 
Total$278,655 $241,398 
The Company’s revenues disaggregated by product category for the three months ended March 31, 2024 and 2023 was as follows (in thousands):
 Three Months Ended March 31,
 20242023
Thrombectomy$187,703 $144,980 
Embolization and Access90,952 96,418 
Total$278,655 $241,398 
Summary of Contract Assets and Liabilities
The following information summarizes the Company’s contract assets and liabilities (in thousands):
March 31, 2024December 31, 2023
Contract assets$18,000 $18,000 
Contract liabilities$7,261 $6,496